KTH and Elekta strengthen collaboration within MedTech

The KTH Royal Institute of Technology and Elekta are deepening their collaboration in innovation, research and education in medical technology. The signing of a letter of intent will take this collaboration to an even more strategic and systematic level.
Elekta is a leading international health sector company, manufacturing software and equipment primarily for cancer radiotherapy, with its headquarters in Stockholm.
“As a leading technical university, we are excited to develop our collaboration with the best in medical technology, and we anticipate numerous joint projects in the future,” said President Anders Söderholm, commenting on the signing of the Memorandum of Understanding (MoU) at KTH.
One of the shared goals is to further strengthen the Stockholm region as a global hub for knowledge, innovation, and research in medical technology and skills development, and to contribute to better healthcare and strengthen the field of radiotherapy.
“This is a unique opportunity with great potential. Skills supply, innovation, and the development of new technology are important elements in which, in the long term, we can also improve cancer care in Sweden and regain our position as a world leader. Ultimately, that is what medical technology is all about: helping people in need,” said Jonas Bolander Executive Vice President.
Elekta and KTH have collaborated in various ways over the years, including through exchanges and projects. However, the MOU will take this collaboration to the next level by facilitating the exchange of expertise and knowledge, joint research applications, and industrial doctoral students, among other things.
The next step is to review ongoing collaborations, identify successful new initiatives and develop a strategy for future work.
From KTH´s side, Niclas Roxhed Professor and Director of the interdisciplinary research centre MedTechLabs and Rebecca Hollertz (Collaboration Leader) are leading the work.
The agreement between KTH and Elekta is valid for three years from 14 May, the date of signing.
Text: Jill Klackenberg
Photo: Magnus Glans